Show
Sort by
-
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial
-
- Journal Article
- A1
- open access
Association between a type 2 inflammatory disease burden score and outcomes among patients with asthma
-
ARIA digital anamorphosis : digital transformation of health and care in airway diseases from research to practice
-
Cabbage and fermented vegetables : from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19
-
Next-generation Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence
-
- Journal Article
- A1
- open access
Nrf2-interacting nutrients and COVID-19 : time for research to develop adaptation strategies
-
Rhinology future trends : 2017 EUFOREA debate on allergic rhinitis
-
- Journal Article
- A1
- open access
The REal Life EVidence AssessmeNt Tool (RELEVANT) : development of a novel quality assurance asset to rate observational comparative effectiveness research studies
-
- Journal Article
- A1
- open access
Quality standards in respiratory real-life effectiveness research : the REal Life EVidence AssessmeNt Tool (RELEVANT) : report from the Respiratory Effectiveness Group - European Academy of Allergy and Clinical Immunology Task Force
-
Prevalence and characteristics of asthma-chronic obstructive pulmonary disease overlap in routine primary care practices
-
Development of the International Severe Asthma Registry (ISAR) : a modified Delphi study
-
- Journal Article
- A1
- open access
Next-generation ARIA care pathways for rhinitis and asthma : a model for multimorbid chronic diseases
-
Rhinology future debates 2017 by EUFOREA : novel treatments and surgical solutions in rhinology
-
- Journal Article
- A1
- open access
Impact of rhinitis on work productivity : a systematic review
-
Electronic clinical decision support system for allergic rhinitis management: MASK e-CDSS
-
Association between blood eosinophil counts and risk of rehospitalization in patients with asthma
-
Association between blood eosinophil count and exacerbation risk in patients with asthma receiving medium- or high-dosage inhaled corticosteroids
-
Allergic rhinitis and its impact on asthma (ARIA) guidelines : 2016 revision
-
MP-AzeFlu provides rapid and effective allergic rhinitis control in real life : a pan-European study
-
- Journal Article
- A1
- open access
Determinants and impact of suboptimal asthma control in Europe: the INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study
-
- Journal Article
- A1
- open access
Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care : in UK primary care: a real-world, retrospective, observational
-
- Journal Article
- A1
- open access
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis
-
- Journal Article
- A2
- open access
Real-world research and its importance in respiratory medicine
-
- Journal Article
- A1
- open access
The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK
-
Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study
-
- Journal Article
- A1
- open access
The hidden burden of adult allergic rhinitis : UK healthcare resource utilisation survey
-
- Journal Article
- A1
- open access
A common language to assess allergic rhinitis control : results from a survey conducted during EAACI 2013 congress
-
Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps
-
Current controversies and challenges in allergic rhinitis management
-
Quality standards for real-world research: focus on observational database studies of comparative effectiveness
-
- Journal Article
- A1
- open access
Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns
-
Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort
-
Challenges of COPD diagnosis
-
Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD
-
- Journal Article
- A1
- open access
InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients: the LIAISON study protocol
-
Integrating real-life studies in the global therapeutic research framework
-
Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis
-
A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis
-
Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis
-
EPOS 2012 : European position paper on rhinosinusitis and nasal polyps 2012 : a summary for otorhinolaryngologists
-
European position paper on rhinosinusitis and nasal polyps 2012
-
The current burden of allergic rhinitis amongst primary care practitioners and its impact on patient management